These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15297505

  • 1. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
    Pfaller MA, Hazen KC, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2004 Aug; 42(8):3607-12. PubMed ID: 15297505
    [Abstract] [Full Text] [Related]

  • 2. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ, ARTEMIS DISK Global Antifungal Surveillance Group.
    Diagn Microbiol Infect Dis; 2009 Sep; 65(1):27-34. PubMed ID: 19679232
    [Abstract] [Full Text] [Related]

  • 3. Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.
    Pfaller MA, Boyken L, Messer SA, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2005 Oct; 43(10):5208-13. PubMed ID: 16207985
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, Fu W, Colombo AL, Rodriguez-Noriega E, Global Antifungal Surveillance Study.
    J Clin Microbiol; 2007 Jun; 45(6):1735-45. PubMed ID: 17442797
    [Abstract] [Full Text] [Related]

  • 6. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp.
    Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG.
    J Clin Microbiol; 2007 Mar; 45(3):796-802. PubMed ID: 17215344
    [Abstract] [Full Text] [Related]

  • 7. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.
    Lee SC, Lo HJ, Fung CP, Lee N, See LC.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647
    [Abstract] [Full Text] [Related]

  • 8. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
    Tan GL, Peterson EM.
    J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Pfaller MA, Messer SA, Boyken L, Rice C, Tendolkar S, Hollis RJ, Diekema DJ.
    J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Fluconazole susceptibility testing of Candida species by flow cytometry.
    Joung YH, Kim HR, Lee MK, Park AJ.
    J Infect; 2007 May; 54(5):504-8. PubMed ID: 17084902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Fluconazole susceptibility of invasive Candida sp isolates as determined by three methods: Bogotá - Colombia].
    Torres D NA, Alvarez M CA, Rondón S MA.
    Rev Chilena Infectol; 2009 Apr; 26(2):135-43. PubMed ID: 19621144
    [Abstract] [Full Text] [Related]

  • 16. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the disc diffusion method with a comparison study for fluconazole susceptibility of Candida strains.
    Kustimur S, Kalkanci A, Mansuroglu H, Senel K.
    Chin Med J (Engl); 2003 Apr; 116(4):633-6. PubMed ID: 12875738
    [Abstract] [Full Text] [Related]

  • 19. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M, Arendrup MC, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, Velegraki A, Rodriguez-Tudela JL, AFST Subcommittee of EUCAST.
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.